GENOMIC TESTING AT GTC

More insight.
Clearer direction.

Explore genomic profiling options for solid tumors and hematologic neoplasms—from tissue and bone marrow to liquid biopsy.

EXPLORE TESTSSolid tumorsHematologyCompare profilesNeed help?
SOLID TUMOR TESTING

Find the right view of a solid tumor.

Explore tissue and liquid biopsy options for DNA, RNA, or combined profiling.

04 TEST OPTIONS
Tissue · DNA + RNA

Solid Tumor Profile Plus

Comprehensive tissue-based profiling that brings DNA alterations together with RNA fusions and expression.

A fuller molecular picture

From established biomarkers to the biology behind them.

Genomic signatures

MSI · TMB · HRD

RNA insights

MET exon 14 skipping · EGFRvIII · AR-V7

More to explore

Known and novel fusions · immune marker expression

SPECIMEN
FFPE tissue
ANALYSIS
DNA + RNA
GENE COVERAGE
>400 DNA · >1,600 RNA genes
Explore this test
Tissue · DNA

Solid Tumor Profile

DNA profiling for mutations and other genomic alterations in solid tumors.

A DNA-first view

A broad look at genomic alterations and signatures.

Genomic signatures

MSI · TMB · HRD

Molecular alterations

Mutations · copy number changes

Repair pathways

Homologous recombination repair genes

SPECIMEN
FFPE tissue
ANALYSIS
DNA
GENE COVERAGE
>400 DNA genes
Explore this test
Tissue · RNA

Solid Tumor Fusion / Expression Profile

RNA profiling for gene fusions, expression and alternative splicing.

See what RNA reveals

Explore the transcript-level changes that shape a tumor.

Splicing

MET exon 14 skipping · alternative splicing

Fusion transcripts

ALK · ROS1 · RET · NTRK and more

Expression

Gene expression across the RNA panel

SPECIMEN
FFPE tissue
ANALYSIS
RNA
GENE COVERAGE
>1,600 RNA genes
Explore this test
Liquid biopsy · cfDNA + cfRNA

Liquid Trace® Solid Tumor

Cell-free DNA and RNA profiling for solid tumors using a liquid biopsy specimen.

More from a liquid biopsy

Bring cell-free DNA and RNA together in a single profile.

RNA insights

MET exon 14 skipping · alternative splicing

Fusion transcripts

Known and novel fusions · gene expression

Additional signals

T- and B-cell clonality

SPECIMEN
Peripheral blood, plasma or CSF
ANALYSIS
cfDNA + cfRNA
GENE COVERAGE
>300 DNA · >1,600 RNA genes
Explore this test

Looking for IHC testing?

Explore GTC’s immunohistochemistry testing alongside its genomic portfolio.

Explore IHC testing ↗
HEMATOLOGY TESTING

See more of the disease.

Choose from DNA, DNA + RNA and cell-free profiling for hematologic neoplasms.

03 TEST OPTIONS
Tissue / marrow · DNA + RNA

Hematology Profile Plus

DNA and RNA profiling to support the assessment of myeloid and lymphoid neoplasms.

A broader view of blood cancers

Bring mutations and molecular expression into focus together.

RNA insights

Fusion transcripts · molecular immunophenotyping

Disease characterization

T- and B-cell clonality · IgHV mutation status

Multiple myeloma

Gene expression and chromosomal risk markers

SPECIMEN
Bone marrow, blood, fresh tissue or FFPE
ANALYSIS
DNA + RNA
GENE COVERAGE
>300 DNA · >1,600 RNA genes
Explore this test
Tissue / marrow · DNA

Hematology Profile

DNA profiling for hematologic neoplasms, including MDS and myeloproliferative neoplasms, with UBA1 analysis relevant to VEXAS.

A focused DNA profile

Look across key genes in myeloid and other hematologic diseases.

Myeloid markers

JAK2 · CALR · MPL

Disease areas

MDS · CMML · MPN

Beyond malignancy

UBA1 analysis relevant to VEXAS

SPECIMEN
Bone marrow, blood, fresh tissue or FFPE
ANALYSIS
DNA
GENE COVERAGE
>300 DNA genes
Explore this test
Liquid biopsy · cfDNA + cfRNA

Liquid Trace® Hematology

Cell-free DNA and RNA profiling for hematologic neoplasms using a liquid biopsy specimen.

Beyond the clonotype

Combine cell-free DNA and RNA to see more of the disease.

RNA insights

Fusion transcripts · gene expression

Clonality

T- and B-cell clonality

Additional information

Chromosomal abnormalities · monitoring support

SPECIMEN
Peripheral blood, plasma or CSF
ANALYSIS
cfDNA + cfRNA
GENE COVERAGE
>300 DNA · >1,600 RNA genes
Explore this test
AT A GLANCE

Compare your options.

Start with specimen and analyte, then explore the profile details for the clinical question.

ProfileDisease areaSpecimenAnalysis
Solid Tumor Profile PlusSolid tumorFFPE tissueDNA + RNA
Solid Tumor ProfileSolid tumorFFPE tissueDNA
Solid Tumor Fusion / Expression ProfileSolid tumorFFPE tissueRNA
Liquid Trace® Solid TumorSolid tumorPeripheral blood, plasma or CSFcfDNA + cfRNA
Hematology Profile PlusHematologyBone marrow, blood, fresh tissue or FFPEDNA + RNA
Hematology ProfileHematologyBone marrow, blood, fresh tissue or FFPEDNA
Liquid Trace® HematologyHematologyPeripheral blood, plasma or CSFcfDNA + cfRNA

Gene counts, specimen requirements and availability may change. Consult the current test information and client services for details.

Liquid Trace on CSF

Explore cell-free DNA and RNA testing for central nervous system neoplasms.

Explore CSF testing ↗

Questions about the right test?

Our client services team can help with test selection, specimen requirements and ordering.